Comparing Extendicare (OTCMKTS:EXETF) & Bioqual (OTCMKTS:BIOQ)

Bioqual (OTCMKTS:BIOQGet Free Report) and Extendicare (OTCMKTS:EXETFGet Free Report) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

Insider & Institutional Ownership

9.4% of Extendicare shares are owned by institutional investors. 39.2% of Bioqual shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and price targets for Bioqual and Extendicare, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bioqual 0 0 0 0 0.00
Extendicare 0 0 5 0 3.00

Earnings & Valuation

This table compares Bioqual and Extendicare”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Bioqual $48.87 million 0.59 -$1.05 million ($1.08) -30.09
Extendicare N/A N/A N/A ($0.26) -92.08

Extendicare has lower revenue, but higher earnings than Bioqual. Extendicare is trading at a lower price-to-earnings ratio than Bioqual, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Bioqual and Extendicare’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Bioqual -2.27% -2.69% -1.50%
Extendicare N/A N/A N/A

Summary

Extendicare beats Bioqual on 7 of the 10 factors compared between the two stocks.

About Bioqual

(Get Free Report)

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

About Extendicare

(Get Free Report)

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.

Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.